HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study

Infectious Agents and Cancer

Volumn 5, Issue 1, 2010, Pages

  Guech Ongey, Mercy ^a   Verboom, Murielle ^b   Pfeiffer, Ruth M ^a   Schulz, Thomas F ^b   Ndugwa, Christopher M ^c   Owor, Anchilla M ^c   Bakaki, Paul M ^d   Bhatia, Kishor ^a   Figueiredo, Constança ^b   Eiz Vesper, Britta ^b   Blasczyk, Rainer ^b   Mbulaiteye, Sam M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B44 ANTIGEN; VIRUS DNA;

ALLELE; ARTICLE; BLOOD; BLOOD ANALYSIS; CELL; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; HLA SYSTEM; HUMAN; HUMAN HERPESVIRUS 8; MAJOR CLINICAL STUDY; NONHUMAN; POPULATION; PRIORITY JOURNAL; SALIVA ANALYSIS; SAMPLE; SARCOMA; SEROPREVALENCE; SICKLE CELL ANEMIA; UGANDA; VIRUS SHEDDING;

EID: 78349235093     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-5-21     Document Type: Article

References (24)

1. Diagnosis and epidemiology of human herpesvirus 8 infection. JN Martin, Semin Hematol 2003 40 2 133 42 10.1016/S0037-1963(03)70005-5 12704590
2. Human herpesvirus 8 epidemiology: what we do and do not know. NH Dukers G Rezza, AIDS 2003 17 12 1717 30 10.1097/00002030-200308150-00001 12891058
3. Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. SM Mbulaiteye,, et al. J Infect Dis 2004 190 8 1382 6 10.1086/424489 15378429
4. Mother-to-child transmission of human herpesvirus-8 in South Africa. M Dedicoat,, et al. J Infect Dis 2004 190 6 1068 75 10.1086/423326 15319855
5. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. D Whitby,, et al. Int J Cancer 2007 120 2 321 8 10.1002/ijc.22205 17066452
6. Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. M Coluzzi,, et al. Med Vet Entomol 2003 17 4 461 4 10.1111/j.1365-2915. 2003.00465.x 14651663
7. Evidence for a recessive major gene predisposing to human herpesvirus 8 (HHV-8) infection in a population in which HHV-8 is endemic. S Plancoulaine,, et al. J Infect Dis 2003 187 12 1944 50 10.1086/375345 12792871
8. Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. KR Alkharsah,, et al. J Infect Dis 2007 195 6 809 16 10.1086/511827 17299710
9. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. EJ Davidson,, et al. Cancer Res 2003 63 2 400 3 12543794
10. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. KS MacDonald,, et al. J Infect Dis 2000 181 5 1581 9 10.1086/315472 10823757
11. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. KJ Jeffery,, et al. J Immunol 2000 165 12 7278 84 11120862
12. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. SM Mbulaiteye,, et al. J Natl Cancer Inst 2003 95 17 1330 5 12953087
13. Bioinformatic integration of biomechanics makes HLA sequencing universally applicable. M Verboom,, et al. Tissue Antigens 2007 70 4 338 9 10.1111/j.1399-0039.2007.00919.x 17767558
14. Fluorotyping of HLA-DRB by sequence-specific priming and fluorogenic probing. M Albis-Camps R Blasczyk, Tissue Antigens 1999 53 3 301 7 10.1034/j.1399-0039.1999.530312.x 10203025
15. Combining assays for estimating prevalence of human herpesvirus 8 infection using multivariate mixture models. RM Pfeiffer,, et al. Biostatistics 2008 9 1 137 51 10.1093/biostatistics/kxm018 17566074
16. HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster. GH Kijak,, et al. Tissue Antigens 2009 73 3 262 9 10.1111/j.1399-0039.2008.01192.x 19254258
17. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. K Cao,, et al. Tissue Antigens 2004 63 4 293 325 10.1111/j.0001-2815.2004.00192.x 15009803
18. Advantage of rare HLA supertype in HIV disease progression. E Trachtenberg,, et al. Nat Med 2003 9 7 928 35 10.1038/nm893 12819779
19. A global network for investigating the genomic epidemiology of malaria. Nature 2008 456 7223 732 7 10.1038/nature07632 19079050
20. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. AV Hill,, et al. Nature 1992 360 6403 434 9 10.1038/360434a0 1280333
21. Common west African HLA antigens are associated with protection from severe malaria. AV Hill,, et al. Nature 1991 352 6336 595 600 10.1038/352595a0 1865923
22. The immunogenetics of human infectious diseases. AV Hill, Annu Rev Immunol 1998 16 593 617 10.1146/annurev.immunol.16.1.593 9597143
23. HLA-DRB1*04 allele is associated with severe malaria in northern Ghana. AD Osafo-Addo,, et al. Am J Trop Med Hyg 2008 78 2 251 5 18256425
24. HLA-B allele frequencies in Cote d'Ivoire defined by direct DNA sequencing: identification of HLA-B*1405, B*4410, and B*5302. JM Ellis,, et al. Tissue Antigens 2001 57 4 339 43 10.1034/j.1399-0039.2001. 057004339.x 11380943